BVS

7.02

2.48% 0.17

Handel nachbörslich: 7.02

Bioventus Inc (BVS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.85

Offen:

$6.89

24-Stunden-Volumen:

172.47K

Relative Volume:

0.46

Marktkapitalisierung:

$455.21M

Einnahmen:

$555.06M

Nettoeinkommen (Verlust:

$-39.48M

KGV:

-11.70

EPS:

-0.6

Netto-Cashflow:

$29.05M

1W Leistung:

+5.41%

1M Leistung:

+5.41%

6M Leistung:

-32.76%

1J Leistung:

+19.19%

1-Tages-Spanne:

$6.86

$7.04

1-Wochen-Bereich:

$6.52

$7.21

52-Wochen-Spanne:

$5.73

$14.38

Bioventus Inc Stock (BVS) Company Profile

Firmenname

Bioventus Inc

Sektor

Healthcare (1160)

Branche

Medical Devices (147)

Telefon

(919) 474-6700

Adresse

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Mitarbeiter

930

Twitter

Nächster Verdiensttermin

2025-03-11

Neueste SEC-Einreichungen

BVS's Discussions on Twitter

Vergleichen Sie BVS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BVS Bioventus Inc	7.02	455.21M	555.06M	-39.48M	29.05M	-0.60
ABT Abbott Laboratories	134.44	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	104.32	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	395.28	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	88.39	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.79	44.46B	5.54B	4.18B	623.10M	7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-17	Hochstufung	JP Morgan	Underweight → Neutral
2023-12-07	Hochstufung	Canaccord Genuity	Hold → Buy
2023-08-09	Hochstufung	Craig Hallum	Hold → Buy
2022-11-22	Herabstufung	Craig Hallum	Buy → Hold
2022-11-09	Herabstufung	Canaccord Genuity	Buy → Hold
2022-11-09	Herabstufung	JP Morgan	Overweight → Underweight
2022-03-15	Eingeleitet	Craig Hallum	Buy
2021-11-15	Fortgesetzt	Morgan Stanley	Overweight
2021-11-10	Fortgesetzt	JP Morgan	Overweight
2021-07-01	Herabstufung	Goldman	Buy → Neutral
2021-03-08	Eingeleitet	Canaccord Genuity	Buy
2021-03-08	Eingeleitet	Goldman	Buy
2021-03-08	Eingeleitet	JP Morgan	Overweight
2021-03-08	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Bioventus Inc Aktie (BVS) Neueste Nachrichten

Jun 19, 2025

(BVS) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 19, 2025

Jun 14, 2025

Do Options Traders Know Something About Bioventus Stock We Don't? - The Globe and Mail

Jun 14, 2025

Jun 06, 2025

(BVS) Proactive Strategies - news.stocktradersdaily.com

Jun 06, 2025

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

Jun 06, 2025

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting - Investing.com

Jun 04, 2025

Bioventus Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025

Jun 02, 2025

Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

Jun 02, 2025

May 30, 2025

Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week

May 30, 2025

Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

May 30, 2025

May 26, 2025

Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World

May 26, 2025

May 19, 2025

Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025

May 18, 2025

Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 18, 2025

May 16, 2025

Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus

May 07, 2025

Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st

May 07, 2025

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 07, 2025